Unitedhealth Group Cdr Stock Fundamentals

UNH Stock   29.01  0.13  0.45%   
UnitedHealth Group CDR fundamentals help investors to digest information that contributes to UnitedHealth Group's financial success or failures. It also enables traders to predict the movement of UnitedHealth Stock. The fundamental analysis module provides a way to measure UnitedHealth Group's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to UnitedHealth Group stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

UnitedHealth Group CDR Company Return On Equity Analysis

UnitedHealth Group's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Return On Equity

 = 

Net Income

Total Equity

More About Return On Equity | All Equity Analysis

Current UnitedHealth Group Return On Equity

    
  0.15  
Most of UnitedHealth Group's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, UnitedHealth Group CDR is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Competition

Based on the latest financial disclosure, UnitedHealth Group CDR has a Return On Equity of 0.1525. This is 100.64% lower than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The return on equity for all Canada stocks is 149.19% lower than that of the firm.

UnitedHealth Group CDR Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining UnitedHealth Group's current stock value. Our valuation model uses many indicators to compare UnitedHealth Group value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across UnitedHealth Group competition to find correlations between indicators driving UnitedHealth Group's intrinsic value. More Info.
UnitedHealth Group CDR is rated first in return on equity category among its peers. It is rated first in return on asset category among its peers reporting about  0.45  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for UnitedHealth Group CDR is roughly  2.20 . Comparative valuation analysis is a catch-all model that can be used if you cannot value UnitedHealth Group by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for UnitedHealth Group's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

UnitedHealth Return On Equity Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses UnitedHealth Group's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of UnitedHealth Group could also be used in its relative valuation, which is a method of valuing UnitedHealth Group by comparing valuation metrics of similar companies.
UnitedHealth Group is currently under evaluation in return on equity category among its peers.

UnitedHealth Fundamentals

About UnitedHealth Group Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze UnitedHealth Group CDR's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of UnitedHealth Group using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of UnitedHealth Group CDR based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
UnitedHealth Group is entity of Canada. It is traded as Stock on NEO exchange.

Pair Trading with UnitedHealth Group

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if UnitedHealth Group position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in UnitedHealth Group will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to UnitedHealth Group could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace UnitedHealth Group when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back UnitedHealth Group - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling UnitedHealth Group CDR to buy it.
The correlation of UnitedHealth Group is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as UnitedHealth Group moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if UnitedHealth Group CDR moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for UnitedHealth Group can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in UnitedHealth Stock

UnitedHealth Group financial ratios help investors to determine whether UnitedHealth Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in UnitedHealth with respect to the benefits of owning UnitedHealth Group security.